Stock screenerAll disclosures →
EDGAR →
ABSI
Conviction 72HealthcareScan · Mon, Aug 10, 2026ABSI$9.01+0.90%
ResistanceSupportVol 14Insider buyVol MA14 2.41M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price9.01
Change+0.90%
Gap+0.34%
Rel volume0.76×
Avg volume2.9M
Avg $ vol23.94M
SMA 208.25
SMA 508.50
SMA 2004.76
Price vs 50+5.99%
Price vs 200+89.26%
MA stackbullish
50/200 cross—
Supertrenddown · 9.17
RSI (14)56
MACD hist0.10
MACD crossbull · 1d
Stoch %K / %D84 / 86
ADX (14)23
+DI / −DI30 / 22
RSI divergence—
MACD divergence—
ATR %+7.69%
ADR %7.45%
52w high11.62
52w low2.30
From 52w high-22.46%
Above 52w low+291.74%
New 52w highNo
SqueezeOff
Bollinger width37.71%
%B0.75
Donchian pos60.87%
Donchian high10.50
Donchian low6.69
AVWAP (52w high)9.72
vs AVWAP high-7.31%
AVWAP (52w low)6.56
vs AVWAP low+37.37%
OBV trendFlat
Chaikin MF (20)-0.17
Today vs 20d0.76×
Avg vol (14d)2.41M
Avg vol (20d)2.9M
Avg $ vol (20d)23.94M
Market cap1.4B
RS 3m (vs SPY)+49.61%
RS 6m (vs SPY)+238.85%
RS line new highNo
Trend template8/8
Technical rank79.1
1 week+13.62%
1 month-15.00%
3 months+52.71%
6 months+234.32%
1 year+208.56%
YTD+149.58%
P/E-12.20
P/B8.17
P/S309.82
P/FCF-14.94
EPS-0.8400
Div yield—
ROE-66.98%
ROA-58.89%
Debt/Eq0.02
Current6.59
EV/EBITDA-12.89
Gross margin—
Net margin—
Rev growth-20.71%
EPS growth-11.71%
Price target13.38
Target upside48.50%
Analyst ratingBuy
Institutional79.45%
Ent. value1.4B
Revenue1.7M
Net income-29.6M
Gross profit—
Free cash flow-94.03M
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNasdaq
Shares out155.91M
Employees140
ListedThu, Jul 22, 2021
Free float108.6M
Float %72.2%
Short interest35.75M
Days to cover7.9d
Short volume63.7%
Squeeze score81 / 100
Next earningsTue, Aug 11, 2026 · after (1d)
EPS forecast−$0.17 · 2 est
Last EPS vs est−$0.19 vs −$0.20
Last surprise+5.0% beat
Setup gradeB
Conviction72 / 100
Pattern quality—
Tech rank79.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance12.02
Support7.14
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ABSI
No recent disclosed trades by Congress in ABSI. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ABSI · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Somaratne Ransi Mudalinayake CMO, Head of R&D · Stock Option (right to buy) · 2026-08-03 | Grant | 383K | — | 2026-08-03 | 2026-08-07 |
Somaratne Ransi Mudalinayake CMO, Head of R&D · Stock Option (right to buy) · 2026-03-03 | Grant | 650K | — | 2026-03-03 | 2026-08-07 |
Szela Mary T Director · Common Stock · 2026-06-30 | Buy | 12.9K | $149K | 2026-06-30 | 2026-07-06 |
McClain Sean Chief Executive Officer · Common Stock · 2026-06-24 | Tax | 59.9K | $603K | 2026-06-24 | 2026-06-26 |
Sirosh Joseph Director · Common Stock · 2026-06-04 | Grant | 10.1K | $0 | 2026-06-04 | 2026-06-08 |
VAN HOUTEN FRANS Director · Common Stock · 2026-06-04 | Grant | 10.1K | $0 | 2026-06-04 | 2026-06-08 |
Rabinovitsj Daniel A Director · Stock Option (right to buy) · 2026-06-04 | Grant | 39.8K | $0 | 2026-06-04 | 2026-06-08 |
Szela Mary T Director · Common Stock · 2026-06-04 | Grant | 10.1K | $0 | 2026-06-04 | 2026-06-08 |
Szela Mary T Director · Stock Option (right to buy) · 2026-06-04 | Grant | 39.8K | $0 | 2026-06-04 | 2026-06-08 |
Rabinovitsj Daniel A Director · Common Stock · 2026-06-04 | Grant | 10.1K | $0 | 2026-06-04 | 2026-06-08 |
SEC filings
EDGAR filings in ABSI · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.